Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo [Immunology and Inflammation]
Lymphocyte-based immunotherapy has emerged as a breakthrough in cancer therapy for both hematologic and solid malignancies. In a subpopulation of cancer patients, this powerful therapeutic modality converts malignancy to clinically manageable disease. However, the T cell- and chimeric antigen receptor T (CAR-T) cell-mediated antimetastatic activity, especially their impacts on microscopic...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Xingkang He, Xin Yin, Jing Wu, Stina L. Wickstrom, Yanhong Duo, Qiqiao Du, Shuhang Qin, Shuzhong Yao, Xu Jing, Kayoko Hosaka, Jieyu Wu, Lasse D. Jensen, Andreas Lundqvist, Alexander I. Salter, Lars Brautigam, Wei Tao, Yuguo Chen, Rolf Kiessling, Yihai Cao Tags: Biological Sciences Source Type: research
More News: Academies | Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Therapy | Hematology | Immunotherapy | Science